Ignite Creation Date:
2025-12-24 @ 10:53 PM
Ignite Modification Date:
2025-12-29 @ 7:42 AM
Study NCT ID:
NCT01131169
Status:
COMPLETED
Last Update Posted:
2021-12-02
First Post:
2010-05-25
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Busulfan, Melphalan, Fludarabine and T-Cell Depleted Allogeneic Hematopoietic Stem Cell Transplantation Followed by Post Transplantation Donor Lymphocyte Infusions
Sponsor:
Memorial Sloan Kettering Cancer Center
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Multiple Myeloma | View |